Devices and methods for treating cardiac tissue

Information

  • Patent Grant
  • 9259267
  • Patent Number
    9,259,267
  • Date Filed
    Wednesday, September 6, 2006
    18 years ago
  • Date Issued
    Tuesday, February 16, 2016
    8 years ago
Abstract
The invention generally relates to devices and methods for treating cardiac tissue, including percutaneous closure of cardiac openings such as a patent foramen ovale (PFO) and obliteration of the cardiac cul-de-sacs. The invention includes a device having at least one elongated member. The elongated member has a first material and a second material interwoven with at least a portion of the first material. The second material is capable of transferring energy to tissue in need of treatment.
Description
TECHNICAL FIELD

The invention generally relates to devices and related methods for treating cardiac tissue. More particularly, the invention features devices and methods of using devices comprising at least two different interwoven materials wherein at least one of the materials is an energy transferring material.


BACKGROUND

The human heart is divided into four compartments or chambers. The left and right atria are located in the upper portion of the heart and the left and right ventricles are located in the lower portion of the heart. The left and right atria are separated from each other by a muscular wall, the interatrial septum, while the ventricles are separated by the interventricular septum.


Either congenitally or by acquisition, abnormal openings, holes, or shunts can occur between the chambers of the heart or the great vessels, causing blood to inappropriately flow there through. Such deformities are usually congenital and originate during fetal life when the heart forms from a folded tube into a four chambered, two-unit system. The septal deformities result from the incomplete formation of the septum, or muscular wall, between the chambers of the heart and can cause significant morbidity.


One such septal deformity or defect, a patent foramen ovale (PFO), is a persistent, one-way, usually tunnel shaped, flap-like opening in the wall between the right atrium and left atrium of the heart. Since left atrial pressure is normally higher than right atrial pressure, the flap typically stays closed. Under certain conditions, however, right atrial pressure exceeds left atrial pressure, creating the possibility for right to left shunting that can allow blood clots to enter the systemic circulation. This is particularly problematic for patients who are prone to forming venous thrombi, such as those with deep vein thrombosis or clotting abnormalities. Patients with a PFO may be prone to a cerebrovascular accident known as a stroke.


Moreover, certain patients are prone to atrial arrhythmias (i.e., abnormal heart rhythms which can cause the heart to pump less effectively). In a common such abnormality, atrial fibrillation, the two upper chambers of the heart (i.e., the left atria and the right atria), quiver instead of beating in coordination with other cardiac chambers. Because the atria do not beat and empty cleanly during atrial fibrillation, blood can stagnate on the walls and form clots that can then pass through the heart and into the brain, causing a stroke or a transient ischemic attack. These clots typically form in a cul-de-sac in the heart called the left atrial appendage due to its tendency to have low or stagnant flow.


Nonsurgical (i.e., percutaneous) tissue treatment and closure of a patent foramen ovale and similar cardiac openings, such as an atrial septal defect or a ventricular septal defect, as well as obliteration of a left atrial appendage, can be achieved using a variety of mechanical devices that are introduced via an artery into a large peripheral vessel, e.g., the femoral vein. These devices typically consist of a structural framework with a scaffold material attached thereto. Currently available devices, however, are often complex to manufacture, are inconsistent in performance, require a technically complex implantation procedure, lack anatomic conformability, and lead to complications (e.g., thrombus formation, chronic inflammation, residual leaks, perforations, device fractures, and conduction system disturbances).


Improved devices, systems, and related methods for treating cardiac tissue and/or closing cardiac openings, such as, for example, a patent foramen ovale, and for obliterating cardiac cul-de-sacs, such as, for example, a left atrial appendage, are therefore needed.


SUMMARY OF THE INVENTION

The present invention provides devices and related methods for treating cardiac tissue. In one aspect, the invention features a device for treating cardiac tissue. The device comprises a first sheath comprising a distal end, a proximal end and a lumen extending between the distal end and proximal end of the sheath. At least one elongated member is slidably disposed within the lumen of the sheath, and the elongated member is comprised of a first material and a second material. The first material is substantially non-conductive, while the second material is an energy transferring material. At least a portion of the second material is interwoven with at least a portion of the first material.


In one embodiment, the second material comprises copper, gold, metal, platinum, silver, iron, lithium, cobalt, nickel, chromium or a combination thereof, while in another embodiment the second material comprises an energy transferring ceramic or glass material. In another embodiment according to this aspect of the invention, the energy to be transferred includes electromagnetic energy, such as, for example, microwave, infrared, visible light waves, ultraviolet light waves, x-ray, gamma ray, or cosmic ray. In a further embodiment, the electromagnetic energy comprises radio frequency energy.


According to one embodiment, at least a portion of the elongated member comprises a straight wire or bristles, while in another embodiment, the second material is disposed on a filament. In another embodiment, at least a portion of the elongated member comprises a sleeve, and in an additional embodiment, at least a portion of the elongated member comprises a braid, coil, knot, spiral or zigzag. Alternatively, in yet another embodiment, at least a portion of the elongated member comprises a tube or a cone. In further embodiments, the elongated member comprises a lumen, and a negative force such as a negative pressure or vacuum is applied to the lumen of the elongated member. In other embodiments of the invention, a negative force is applied to the lumen of the sheath, while in a further embodiment the sheath is joined to a vacuum source.


In one embodiment, the device comprises a second sheath comprising a lumen for slidably receiving the first sheath. In additional embodiments, a negative pressure such as a vacuum is applied to the second sheath. In another embodiment, the second sheath is joined to a vacuum source. In a further embodiment, the second sheath is axially disposed within the lumen of the first sheath. In an even further embodiment, the elongated member is slidably receivable within the second sheath, while in another embodiment, the second sheath is axially disposed within a lumen of the elongated member.


In another embodiment of the invention, the elongated member is operatively joined to an actuator. In one embodiment, movement of the actuator causes movement of the elongated member in an axial direction in relation to the sheath. In other embodiments, the sheath is operatively joined to an actuator.


In another embodiment, the elongated member comprises a distal end and a proximal end. In a further embodiment, the elongated member comprises a wire. The wire comprises an open ended loop, the loop comprising a hairpin turn, for example, at the distal end of the elongated member and two free ends at the proximal end of the elongated member. According to one embodiment, at least one free end of the wire is affixed to an actuator. In another embodiment, movement of the actuator in a distal direction unfurls a portion of the elongated member from the lumen of the sheath moving the distal end of the elongated member even further in the distal direction. In a further embodiment, movement of the elongated member in the distal direction places at least a portion of the second material in contact with the cardiac tissue in need of treatment. In yet a further embodiment, movement of the actuator in a proximal direction retracts a portion of the elongated member inside the lumen of the sheath and moves the distal end of the elongated member in the proximal direction.


In another embodiment of the invention, the elongated member comprises a sleeve comprising an exterior surface and an interior surface. In one embodiment, the exterior surface of the sleeve is affixed to an actuator. In a particular embodiment, the sleeve comprises a first position in which a portion of the elongated member comprising the second material interwoven with the first material is located on the interior surface of the sleeve. In a further embodiment, movement of the actuator in a proximal direction transitions the sleeve into a second position wherein at least a portion the interwoven second material is located on the exterior surface of the sleeve.


Another embodiment of the invention features the interior surface of the sleeve affixed to an actuator. According to one embodiment, the sleeve comprises a first position in which the portion of the elongated member comprising the second material interwoven with the first material is located on the exterior surface of the sleeve. In another embodiment, movement of the actuator in a proximal direction transitions the sleeve into a second position wherein at least a portion the interwoven second material is located on the interior surface of the sleeve.


A further aspect of the invention includes a device for treating cardiac tissue. The device comprises at least one elongated member including a first material and a second material. The first material is a substantially non-conductive material, while the second material is an energy transferring material and at least a portion of the second material is interwoven with at least a portion of the first material. In one embodiment, the second material comprises copper, gold, metal, platinum, silver, iron, lithium, cobalt, nickel, chromium, or a combination thereof. In another embodiment, the second material comprises a glass or ceramic material.


Another aspect of the invention features a method for treating cardiac tissue. The method comprises the step of advancing a device to a position adjacent to cardiac tissue that is in need of treatment. The device includes a first sheath and at least one elongated member slidably disposed within a lumen of the sheath, the elongated member comprising a first material and a second material. The first material is substantially a non-conductive material. At least a portion of the second material is interwoven with at least a portion of the first material. The second material is capable of transferring energy from an energy source. The method further comprises the steps of advancing the elongated member through the lumen of the sheath wherein at least a portion of the second material comes into contact with the cardiac tissue in need of treatment, and applying the energy source to the second material to transfer energy to the cardiac tissue.


In one embodiment of this method of the invention, the elongated member comprises a wire, having an open ended loop. The loop comprises a hairpin turn at a distal end of the elongated member and two free ends at a proximal end of the elongated member. In another embodiment, at least one free end of the wire open-ended loop is operatively joined to an actuator. In a particular embodiment, movement of the actuator in the distal direction unfurls a portion of the elongated member from the lumen of the sheath, thereby moving the distal end of the elongated member in the distal direction. In an additional embodiment, the method further comprises the step of moving the actuator in the distal direction to place at least a portion of the second material in contact with the cardiac tissue in need of treatment. In a further embodiment, movement of the actuator in the proximal direction retracts a portion of the elongated member within the lumen of the sheath and moves the distal end of the elongated member in the proximal direction.


According to one embodiment, energy comprises microwave, infrared, visible light waves, ultraviolet light waves, x-ray, gamma ray, or cosmic ray. In another embodiment, the energy comprises radio frequency energy.


A further embodiment according to this aspect of the method of the invention comprises the step of attaching a vacuum source in communication with the lumen of the first sheath or the second sheath. The method of the invention can further comprise the step of applying a negative pressure to the lumen of the first sheath or the second sheath. In a further embodiment, the negative pressure is provided by a vacuum generating source, e.g., a pump.


In an additional embodiment, the device of the invention comprises a second sheath having a lumen wherein the first sheath is axially disposed within the second sheath. In one embodiment, the method comprises the step of applying a negative force, e.g., negative pressure to the lumen of the second sheath. In a further embodiment, the device comprises a second sheath having a lumen and the second sheath is axially disposed within the lumen of the first sheath. In a further embodiment, the elongated member is slidably receivable in the second sheath. Alternatively, the elongated member is fixed and the sheath is slideably moveable over the elongated member.


A further aspect of the invention features a method for treating cardiac tissue and comprises the step of advancing a device to a position adjacent to cardiac tissue in need of treatment. The device includes at least one elongated member comprising a first material and a second material. The first material is a substantially non-conductive material. The second material is an energy transferring material. At least a portion of the second material is interwoven with at least a portion of the first material, and the second material is capable of transferring energy from an energy source. This aspect also includes the steps of contacting at least a portion of the second material with the cardiac tissue in need of treatment, and transferring energy to the cardiac tissue in need of treatment.





BRIEF DESCRIPTION OF THE DRAWINGS

In the drawings, like reference characters generally refer to the same parts throughout the different views. Also, the drawings are not necessarily to scale, emphasis instead generally being placed upon illustrating the principles of the invention.



FIG. 1A is a schematic side view of a device for treating cardiac tissue, according to an illustrative embodiment of the invention.



FIG. 1B is a schematic side view of a device for treating cardiac tissue including a vacuum source and vacuum cone according to another embodiment of the invention.



FIG. 1C is a schematic view of a cross section in FIG. 1A taken at 1B-1B.



FIG. 2A is a partial cross-sectional view of a distal end of a device for treating cardiac tissue, the device comprising an elongated member retracted within a lumen of the sheath of the device, according to an illustrative embodiment of the invention.



FIG. 2B is a partial cross-sectional view of the distal end of a device for treating cardiac tissue as illustrated in FIG. 2A, with the elongated member unfurled beyond the distal end of the sheath, according to an illustrative embodiment of the invention.



FIG. 2C is a partial cross-sectional view of the distal end of the device for treating cardiac tissue as illustrated in FIG. 2A, with the elongated member extended distally beyond the lumen of the sheath and in proximity to tissue in need of treatment, according to an illustrative embodiment of the invention.



FIG. 2D is a schematic view of a cross section in FIG. 2C taken at 2D-2D.



FIG. 3A is a partial cross-sectional view of a distal end and proximal end of a device for treating cardiac tissue, the device comprising an elongated member in the form of a sleeve and a cable for manipulating the elongated member, according to an illustrative embodiment of the invention.



FIG. 3B is a schematic view of a cross section in FIG. 3A taken at 3B-3B.



FIG. 3C is a partial cross-sectional view of the device illustrated in FIG. 3A after the elongated member is manipulated in the direction indicated by direction arrow 112 in FIG. 3A, according to an illustrative embodiment of the invention.



FIG. 3D is a schematic view of a cross section in FIG. 3C taken at 3D-3D.



FIG. 4 is a schematic side view of a distal end of a device for treating cardiac tissue, the device comprising a first sheath, an elongated member and a second sheath surrounding the first sheath, according to an illustrative embodiment of the invention.



FIG. 5 is a schematic side view of a distal end of a device for treating cardiac tissue, the device comprising a first sheath, an elongated member and a second sheath within the lumen of the first sheath, according to an illustrative embodiment of the invention.



FIG. 6 is a schematic side view of a distal end of a device for treating cardiac tissue, the device comprising an elongated member having a first material and a second material interwoven with a portion of the first material, according to an illustrative embodiment of the invention.





DESCRIPTION OF THE INVENTION

The present invention features devices and related methods for treating cardiac tissue. The cardiac tissue in need of treatment includes, for example, cardiac septa and tissue of the left and right atria. The invention is also useful in closing various cardiac openings, for example, a patent foramen ovale (PFO), an atrial septal defect, or a ventricular septal defect.


The present invention features systems and related methods for closing cardiac openings, such as, for example, a PFO, described below. Throughout the description, the terms proximal and distal refer to the position of elements relative to the operator of the exemplary apparatus. Proximal is that portion of the device closer to the operator and distal is that portion of the device further away from the operator.



FIG. 1A is a schematic side view of an exemplary device 2 for treating cardiac tissue 18, the device 2 comprising a sheath 4 having a distal end 6, a proximal end 8, and a lumen 10 that extends between the distal end 6 and proximal end 8 of the sheath 4, a handle 30, and an actuator 32 on the handle 30. The exemplary sheath 4 extends from a proximal end 8 at the handle 30 to a distal end 6. In one embodiment, shown in FIG. 1A, the device 2 further features at least one elongated member 12 slidably disposed within the lumen 10 of the sheath 4.



FIG. 1B illustrates yet another embodiment of the device 2 including a vacuum source 102. This embodiment may feature a cone 106 disposed at the distal end 6 of the sheath 4.


The vacuum source 102 is used to apply negative pressure through the vacuum cone 106 to stabilize the sheath 4 while delivering the elongated member 12 into, for example, a PFO tunnel. The vacuum applied to stabilize the sheath 4 may also have the advantage of collapsing the tunnel of the PFO. The lumen 128 of the vacuum cone 106 may be in communication with the lumen 10 of the sheath 4.


A cone, as used herein, means any tubular shape or any tubular shape with a flared end. In a preferred embodiment, the cone 106 includes a tube having a flared end, i.e., the diameter of the distal end 96 of the cone 106 is greater than the diameter of the proximal end 132 of the cone 106. The flare may begin at the proximal end 132 of the cone 106 and extend gradually to the distal end of the cone 106 as illustrated in FIG. 1B, or, alternatively, the flare may begin anywhere along the long axis of the cone 106 and extend to the distal end of the cone 106 (not shown). The distal end of the cone 106 may be circular, oval, U-shaped or any other shape suitable for interfacing with intracardiac tissue. According to the invention, the cone 106 and vacuum source 102 may or may not be present and the invention is not limited to an apparatus including a vacuum or other source of negative pressure. Furthermore, the cone 106 may be applied to the distal end of any sheath in the device and is not limited to the sheath illustrated.


With continued reference to FIG. 1B, in one embodiment, the cone 106 includes a single lumen 128 extending from the proximal end 132 of the cone 106 to the distal end of the cone 106. The lumen 128 of the cone 106 houses the elongated member 12 and may be in communication with the lumen 10 of the sheath 4. In one embodiment, the lumen 128 is in fluid communication with the lumen 10 of the sheath 4. Alternatively, the cone 106 has a plurality of lumens 128 (not shown). One of the plurality of lumens 128 houses the elongated member 12. At least one other of the plurality of lumens 128 is in fluid communication with the lumen 10 of the sheath 4.


Referring still to FIG. 1B, in a preferred embodiment, a vacuum source 102 is operatively joined to the lumen 10 of the sheath 4 to the lumen 128 of the cone 106.


With further reference to FIG. 1B, the elongated member 12 extends through the lumen 10 of sheath 4. In one embodiment, the distal end 33 of the elongated member 12 transitions from a first position, where the distal end 33 of the elongated member 12 is housed within the lumen 10 to a second position, where the distal end 33 of the elongated member 12 is positioned beyond the distal end of the sheath 4 or the distal end of the cone 106 in embodiments including a cone 106.


According to one embodiment of the invention, the elongated member 12 includes a first material 14 and a second material 16. In one embodiment, at least a portion of the second material 16 is interwoven with at least a portion of the first material 14. In a particular embodiment, at least the second material 16 interwoven with first material 14 is an energy transferring material that can transfer energy from an energy source 34 to, for example, adjacent cardiac tissue. The second material 16 may be in the form of a thread, filament cord, rope, ribbon, plate or sheet, for example. In yet another embodiment, the elongated member 12 is transitioned from within the sheath 4 to extend beyond the distal end 6 of the sheath 4 to place the distal end of the elongated member 12 including the second material 16 in direct contact or, alternatively in indirect contact, for example, through water or saline, with cardiac tissue 18 in need of treatment.


The elongated member 12 can be any shape depending on the intended use of the device 2 and/or the user's preference. In certain embodiments, the elongated member 12 comprises a straight wire or, alternatively, one or more bristles (not shown) at the distal end 33 of the elongated member 12. In another embodiment, the elongated member 12 comprises a sleeve. In other embodiments, the elongated member 12 comprises a braid, coil, knot, spiral or zigzag shape. Alternatively, the elongated member 12 can be in the shape of a tube or a cone. In certain embodiments, the elongated member 12 includes a lumen. In other embodiments, the device of the invention comprises two or more elongated members 12. Each elongated member 12 can be manipulated independently or in unison with the other(s) in the manner described below.


In a particular embodiment, the second material 16 may be positioned on one or more bristles or braided, coiled, knotted, spiral or zig zag or bonded with the first material 14 on the elongated member 12. For example, the first material 14 may be an insulator of the second material 16. Uninsulated portions of the second material 16 are contacted with the tissue in need of treatment. Alternatively, the elongated member 12 may include only the second material 16.


With respect to the material of the elongated member 12, by “interwoven” it is meant that at least a portion of the first material 14 and a portion of the second material 16 are connected closely by being in direct contact with each other, e.g., threaded, woven through or overlapping the other or indirect contact. By “direct contact” it is meant that at least a portion of the first material 14 and a portion of the second material 16 are physically touching each other. By “indirect contact” it is meant that at least a portion of the first material 14 and a portion of the second material 16 are in physical contact with a common object or common third material. By “threaded” it is meant that one material in the form of a thread or wire is physically passed into or through the other.


In one embodiment according to the invention, the first material 14 and the second material 16 of the elongated member are different compositions. According to one embodiment, the first material 14 comprises, for example, a polymer, such as a plastic, for example, nylon or polyester. The second material 16 comprises any material capable of transferring energy, for example, electromagnetic energy, from an energy source to a target tissue, for example, cardiac tissue. In one embodiment, the second material is, for example, copper, gold, metal, platinum, silver, iron, lithium, cobalt, nickel, chromium, glass, ceramic or a combination thereof. The electromagnetic energy transferred may be, for example, one of microwave, infrared, visible light waves, ultraviolet light waves, x-ray, gamma ray, laser energy, or cosmic ray. In a particular embodiment, the electromagnetic energy is radio frequency energy.


According to one embodiment of the invention, at least a portion of the second material 16 is interwoven with at least portion of the first material 14. For example, the materials 14, 16 can cross each other one or more times, be braided together, threaded through one another, twisted together, coiled together, woven through each other, and/or knotted together. Alternatively, the materials 14, 16, when placed adjacent to each other, can be collectively formed into the shape of a braid, coil, knot, spiral, zigzag, straight wire, or bristles. The material 14, 16 may be laminated or crimped together. The second material 16 extends from the energy source 34 to at least the distal end of the elongated member 12.


Referring now to FIG. 1A, another embodiment of the invention features the sheath 4 operatively joined to an actuator 32, positioned on, for example, a handle 30, wherein movement of the actuator 32 causes axial movement of the sheath 4 relative to the stationary elongated member 12. In another embodiment, the elongated member 12 is operatively joined to the actuator 32 wherein movement of the actuator causes axial movement of the elongated member 12 relative to the stationary sheath 4. In one embodiment, the actuator is a knob or a button.



FIG. 1C is a schematic view of a cross section in FIG. 1A taken at 1C-1C. As shown in FIG. 1C, one embodiment of the invention features the elongated member 12 located within the lumen 10 of the sheath 4.



FIG. 2A is a partial cross-sectional view of a distal end of a device 2 for treating cardiac tissue, the device 2 comprising an elongated member 12 retracted within a lumen 10 of the device 2 according to an illustrative embodiment of the invention. As shown in FIG. 2A, one embodiment features an elongated member 12 comprising a distal end 33 and a proximal end 50. According to the illustrative embodiment, the elongated member 12 is, for example, a single wire such as for example, a single braided wire comprising a hairpin turn 36 at the distal end 33 of the elongated member 12 to form an open loop configuration with the two free ends 52 of the wire located at the proximal end 50 of the elongated member 12. In one embodiment, the elongated member 12 is in the form of a wire that forms a closed loop configuration at the distal end 33 of the elongated member 12, with both of the ends 52 of the wire joined to each other or joined to a common object, for example, directly or indirectly to an actuator, at the proximal end 50 of the elongated member 12.


In one embodiment, the second material 16 follows the path of the first material 14 forming a bipolar device. Alternatively, the second material 16 partially follows the path of the first material 14, forming a unipolar device.


With continued reference to the embodiment shown in FIG. 2A, at least one end 52 of the wire is operatively joined to an object, for example, a carrying cable 20. According to one embodiment, the carrying cable 20 is connected to an actuator (not shown) such that actuation of the actuator effectuates movement of the cable 20 and the elongated member 12. In a particular embodiment, movement of the actuator causes the elongated member 12 to move axially in relation to the sheath 4, i.e., in a motion-parallel to the sheath 4 (as indicated by direction arrows 100 and 102). In another embodiment, movement of the actuator causes the elongated member 12 to move in a circumferential motion, i.e., rotational movement of the circumference of the loop in one or more directions as indicated by arrows 108 and 110.


In a further embodiment, the one end 52 of the wire that is not joined to the cable 20 is fixed within the device 2. In another embodiment, as shown in FIG. 2B, axial movement of the cable 20 in the distal direction allows the elongated member 12 to unfurl from the lumen 10 of the sheath 4. By unfurl it is meant that the distal end portion 46 of the elongated member 12 moves in the distal direction to extend the length of the elongated member 12 from the proximal end 50 to the distal end 33 of the elongated member 12 while the end 52 remains stationary (similar to that of a bicycle chain, for example, with one end fixed) as indicated by direction arrows 104 and 106 in FIG. 2A, relative to the sheath 4. The distal end 33 of the unfurled elongated member 12 can be extended beyond the distal end 6 of the sheath 4. Alternatively, axial movement of the cable 20 in the proximal direction can allow the distal end 33 of the elongated member 12 to move in the proximal direction and retract the distal end 33 of the elongated member further inside the lumen 10 of the sheath 4.



FIG. 2C is a partial cross-sectional view of the distal end 6 of the device 2 for treating cardiac tissue 18 as illustrated in FIG. 2A, with the elongated member 12 extended distally beyond the lumen 10 of the sheath 4 and in proximity to tissue in need of treatment according to an illustrative embodiment of the invention. As illustrated in FIG. 2C, manipulation of the elongated member 12 according to each of the embodiments described above allows the portion 22 of the elongated member 12 comprising the first interwoven materials 14 and the second interwoven material 16 to be placed in a desired location within a patient's body. Energy is transferred from an energy source 34 to the second material 16 in contact with the target tissue 18 and from the second material 16 to the target tissue 18.


In a preferred embodiment, manipulation of the elongated member 12 carries the second material 16 into the PFO tunnel. Upon further manipulation of the elongated member 12, the distal end of the elongated member retracts proximally, and leaves the PFO tunnel, and the second material transfer energy to the septum tissue along the track, and therefore causes the target tissue to fuse together.



FIG. 2D is a schematic view of a cross section in FIG. 2C taken at 2D-2D. As shown in FIG. 2D, according to the exemplary embodiment of FIG. 2C, the elongated member 12, for example, is a wire having a hairpin turn. One end of the wire is attached to the cable 20. The elongated member 12 is axially positioned within the lumen 10 of the sheath 4.



FIG. 3A is a partial cross-sectional view of a distal end portion 38 of a device 2 for treating cardiac tissue, the device 2 comprising an elongated member 12 in the form of a sleeve and a cable 20 for manipulating the elongated member 12 according to an illustrative embodiment of the invention. According to one embodiment, the sleeve 12 comprises an interior surface 42 and an exterior surface 44. In the embodiment shown in FIG. 3A, the portion of the elongated member 12 comprising the second material 16 interwoven with the first material 14 is located at least on the interior surface 42 of the sleeve 12.



FIG. 3B is a schematic view of a cross section in FIG. 3A taken at 3B-3B. In one embodiment, shown in FIG. 3B, the sleeve 12, located within the lumen 10 of the sheath 4, comprises an interior surface 42 and an exterior surface 44, wherein the portion of the sleeve 12 comprising the interwoven second material 16 is located on the interior surface 42 of the sleeve 12.


Referring now to the embodiment shown in FIG. 3A, the portion of the elongated member 12 comprising the second material 16 interwoven with the first material 14 is initially located on the interior surface 42 of the sleeve 12. According to one embodiment, the cable 20 is operatively joined to the exterior surface 44 of the sleeve 12. Referring now to FIG. 3C, axial movement of the cable 20 proximally in the direction indicated by direction arrow 112 lengthens the exterior surface 44 and shortens the interior surface 42 of the sleeve. At least a portion of the inner surface of the sleeve 12 becomes everted and at least a portion of the sleeve 12 comprising the interwoven second material 16 is relocated from the interior surface 42 to the exterior surface 44 of the sleeve 12. In one embodiment for treating cardiac tissue, the portion of the everted sleeve 12 comprising the interwoven second material 16 contacts the tissue in need of treatment when the second material 16 on the distal end of the sleeve 12 is extended beyond the distal end of the sheath 4, and electromagnetic energy from the energy source is transferred from the second material 16 to the tissue.


Alternatively, in another embodiment (not shown), the cable 20 is operatively joined to the interior surface 42 of the sleeve 12. Axial movement of the cable 20 in a distal direction lengthens the exterior surface 44 and shortens the interior surface 42 of the sleeve such that at least a portion of the interior surface 42 of the sleeve 12 becomes everted and at least a portion of the sleeve 12 comprising the interwoven second material 16 is relocated to the distal end of the sleeve 12 and the exterior surface 44 of the inverted sleeve 12. In one embodiment for treating cardiac tissues, the portion of the everted sleeve 12 comprising the interwoven second material 16 contacts the tissue in need of treatment and electromagnetic energy from the energy source is transferred from the second material 16 to the tissue.



FIG. 3D is a schematic view of a cross section in FIG. 3C taken at 3D-3D. In the exemplary embodiment, shown in FIG. 3D, the sleeve 12 is located within the lumen 10 of the sheath 4 and the portion of the sleeve 12 comprising the interwoven second material 16 is located on both the interior surface 42 and the exterior surface 44 of the inverted sleeve 12.


Referring now to FIGS. 3C and 3D, according to one embodiment of the invention, the sheath 4 of the device 2 moves relative to the sleeve 12 such that movement of the sheath 4 in the proximal direction exposes the sleeve 12 beyond the distal end of the sheath 4. In another embodiment, the sleeve 12 moves relative to the sheath 4, such that movement of the sleeve 12 in the distal direction exposes the sleeve 12 beyond the distal end of the sheath 4.


In further embodiments of the invention of the device 2, the proximal end 8 of the sheath 4 is coupled to a vacuum source to allow functional communication with the lumen 10 of the sheath 4. This configuration allows the user to apply negative pressure, i.e., suction, to the targeted cardiac tissue 18 as the distal end of the sheath 4 is applied to the tissue 18. The negative pressure vacuum can be used to draw the cardiac tissue toward the second material 16. With the tissue in contact with the second material 16, energy transfers from the second material 16 directly to the tissue. In one embodiment, the negative pressure from the vacuum source is maintained while the energy is applied to the tissue.



FIG. 4 is a schematic side view of a distal end 38 of a device 2 for treating cardiac tissue, the device 2 comprising a first sheath 4, an elongated member 12 and a second sheath 24 surrounding the first sheath 4 according to an illustrative embodiment of the invention. The elongated member 12 may be any one of the elongated members illustrated in FIGS. 1A-1C, 2A-2D, or 3A-3D and described in the corresponding text. In one embodiment, as illustrated in FIG. 4, the lumen 26 of second sheath 24 surrounds the first sheath 4 and the first sheath 4 is located within the lumen 26 of the second sheath 24. In another embodiment, the second sheath 24 is functionally joined to a vacuum source, for example, at the proximal end 28 of the second sheath 24.



FIG. 5 is a schematic side view of a distal end 38 of a device 2 for treating cardiac tissue, the device comprising a first sheath 4, an elongated member 12 and a second sheath 24 within the lumen 10 of the first sheath 4, according to an illustrative embodiment of the invention. In one embodiment, as shown in FIG. 5, the second sheath 24 is axially positioned within the lumen 10 of the first sheath 4 and surrounds the elongated member 12 such that the elongated member 12 is located within the lumen 26 of the second sheath 24. In another embodiment (not shown), the second sheath 24 is within the lumen 10 of the first sheath 4 and adjacent to the elongated member 12. In one embodiment, the second sheath 24 is functionally joined to a vacuum source, at, for example, a proximal end 28 of the second sheath 24. In an even further embodiment (not shown), the elongated member 12 comprises a lumen, and the second sheath 24 functionally joined to the vacuum source is axially positioned within the lumen of the elongated member 12. The elongated member 12 may be any one of the elongated members illustrated in FIGS. 1A-1C, 2A-2D, or 3A-3D and described in the corresponding text.


The first sheath 4 and the second sheath 24 can be any shape suited to its function. For example, the sheath 4 or sheath 24 can be tubular or funnel shape. The sheath 4 or sheath 24 can have a lumen of uniform or variable diameter. For example, the sheath 4 or sheath 24 in a particular embodiment includes a flared distal end. In another embodiment, the sheath 4 or sheath 24 comprises an invertible sleeve.



FIG. 6 is a schematic side view of a distal end 38 of a device 2 for treating cardiac tissue, the device 2 comprising an elongated member 12 having a first material 14 and a second material 16 interwoven with a portion of the first material 14, according to an illustrative embodiment of the invention. In one embodiment, the second material 16 of the elongated member 12 is an energy transferring material. The elongated member 12 includes, for example, a flared distal end 30. The portion of the elongated member 12 having at least a portion of the interwoven second material 16 is located on the flared distal end 30. In a further embodiment, the elongated member 12 comprises a uniform fixed diameter. In other embodiments, the elongated member 12 comprises a lumen that is functionally joined to a vacuum source for the application of negative pressure to cardiac tissue.


Another aspect of the invention features a method for treating cardiac tissue. The method comprises the steps of advancing a device 2 according to the invention to a position adjacent to cardiac tissue 18 in need of treatment, the device 2 includes a sheath 4 and at least one elongated member 12 slidably disposed with a lumen 10 of the sheath 4. In one embodiment, the elongated member 12 includes a first material 14 and a second material 16. At least a portion of the second material 16 is interwoven with a portion of the first material 14. As described above with respect to other embodiments, the second material 16 is capable of transferring energy, for example, electromagnetic energy, from an energy source. According to this embodiment, the method comprises the step of advancing the elongated member 12 through the lumen 10 of the sheath. At least a portion of the second material 16 is placed into contact with cardiac tissue in need of treatment 18. The method further includes the step of applying energy from the energy source to the second material 16 to transfer energy to the cardiac tissue 18 in need of treatment.


In one embodiment according to this aspect of the invention, the energy applied to the cardiac tissue includes one of microwave, infrared, visible and ultraviolet light waves, x-ray, gamma ray, or cosmic ray. In another embodiment, the energy is radio frequency energy.


According to a further embodiment of the method of the invention, an operator provides an elongated member 12 including a wire having a hairpin turn 36 at a distal end 33 of the elongated member 12 to form an open ended loop having two ends 52 of the wire at a proximal end of the elongated member 12. At least one end 52 of the wire is operatively joined to an actuator 32. Actuating the actuator 32 in the distal direction unfurls a portion of the elongated member 12 from the lumen 10 of the sheath 4 and moves the distal end 36 of the elongated member 12 in the distal direction. In an additional embodiment, the method further comprises the step of actuating the actuator 32 to move the elongated member 12 distally to place at least a portion of the second material 16 in contact with the cardiac tissue 18 in need of treatment. In a further embodiment, actuating the actuator 32 to move the elongated member 12 in the proximal direction retracts a portion of the elongated member 12 within the lumen 10 of the sheath 4 and moves the distal end 36 of the elongated member 12 in the proximal direction.


A further embodiment of the invention includes an additional step of attaching a vacuum source to the lumen 10 of the sheath 4. According to this embodiment, a vacuum or negative pressure, i.e., suction, is applied to the cardiac tissue 18 to draw the cardiac tissue 18 toward the device 2. In another embodiment, the device 2 comprises a second sheath 24 having a lumen 26, and the method comprises an additional step of attaching a vacuum source to the lumen 26 of the second sheath 24. According to this embodiment, a vacuum can be applied to cardiac tissue to draw the tissue toward the device 2. In both of these embodiments, the cardiac tissue drawn toward the device 2 is contacted with the second material 16 and energy is transferred from the second material 16 to the tissue 18. The vacuum or negative pressure can also be maintained on the tissue while the energy is being applied to the tissue.


A further aspect of the invention includes a method for treating cardiac tissue comprising the step of advancing a device 2 to a position adjacent to cardiac tissue in need of treatment, the device 2 having at least one elongated member 12 comprising a first material 14 and a second material 16. At least a portion of the second material 16 is interwoven with at least a portion of the first material 14. The second material 16 is capable of transferring energy from an energy source to a target tissue, for example, cardiac tissue. The method further comprises the steps of advancing the elongated member 12 through the body of a patient until at least a portion of the second material 16 comes into contact with the cardiac tissue in need of treatment, and applying the energy source to the second material 16 to transfer energy to the cardiac tissue in need of treatment.


In yet another aspect, the invention provides methods for percutaneously closing a PFO using a device 2 such as the device according to the invention depicted in FIGS. 1-6. In one exemplary embodiment, an operator, e.g., a physician, advances the device 2 into the patient's heart with the elongated member 12 retracted within the lumen 10 of the sheath 4. The operator then positions the distal end 6 of the sheath 4 in the right atrium proximate the PFO. With the device 2 positioned as such, the elongated member 12 is deployed into the tunnel of the PFO. As described above, the elongated member 12 is manipulated such that the portion of the elongated member comprising the interwoven second material 16 is exposed to the patient's tissue surface located within the tunnel of the PFO. The second material 16 is connected to an energy source, and energy is transferred from the second material 16 to the tissue surface to close the PFO. The physician then retracts the elongated member 12 from the PFO and removes the device 2 from within the patient.


In a similar embodiment, the device 2 comprising the elongated member 12 is advanced within a patient as described above and is placed adjacent to the right atrial wall of the heart. The elongated member 12 comprises a vacuum which is placed in contact with the right atrial wall, and the portion of the elongated member 12 comprising the interwoven second material 16 is placed in contact with the tissue of the right atrial wall. The vacuum is then activated, attaching the elongated member 12 to the right side of the fossa ovalis. Energy is then delivered to the second material 16 from an energy source, and the energy is transferred from the second material 16 to the fossa ovalis. The energy is absorbed by the surrounding cardiac tissue to close the PFO.


In yet another embodiment of the method according to the invention, the elongated member of the device described herein may be used to delivery energy to the tissues within the tunnel of a PFO as described in co-owned application titled, “In tunnel electrode for sealing intra-cardiac defects”, co-filed on the same date as the instant application and incorporated by reference in its entirety herein.


Variations, modifications, and other implementations of what is described herein will occur to those of ordinary skill in the art without departing from the spirit and the scope of the invention. The invention is not to be defined only by the preceding illustrative description.

Claims
  • 1. A device for treating cardiac tissue, comprising: a first sheath comprising a distal end, a proximal end and a lumen extending between the distal end and proximal end of the sheath;an elongated member slidably disposed within the lumen of the first sheath, the elongated member having two ends both affixed at a proximal end to form a closed loop having a hairpin turn at a distal end, wherein the elongated member is adapted to unfurl from the lumen of the first sheath by advancing one affixed end of the elongated member toward the distal end of the elongated member thereby advancing the hairpin turn beyond the distal end of the first sheath, the elongated member further comprising a first substantially non-conductive material, and a second energy transferring material at a portion of the elongated member, wherein when the elongated member is unfurled from the lumen of the first sheath, the portion of the elongated member with the second energy transferring material forms the hairpin turn extending beyond the distal end of the first sheath; andan actuator operatively joined to the proximal end of the elongated member, wherein when the elongated member is unfurled and the device is actuated, the second energy transferring material is rotated about the hairpin turn.
  • 2. The device of claim 1 wherein movement of the actuator causes the elongated member to unfurl from the lumen of the first sheath.
  • 3. The device of claim 2 wherein extension of the elongated member in the distal direction places at least a portion of the second energy transferring material in contact with the cardiac tissue in need of treatment.
  • 4. The device of claim 1 wherein the second energy transferring material comprises a metal selected from the group consisting of copper, gold, platinum, silver, iron, lithium, cobalt, nickel, and chromium, or a combination thereof.
  • 5. The device of claim 1 where in the second energy transferring material comprises an energy transferring ceramic or glass material.
  • 6. The device of claim 1 wherein the second energy transferring material is adapted to transfers energy selected from the group consisting of microwave, infrared, visible light waves, ultraviolet light waves, x-ray, gamma ray, and cosmic ray.
  • 7. The device of claim 1 wherein the second energy transferring material is adapted to transfer radio frequency energy.
  • 8. The device of claim 1 wherein the second energy transferring material is selected from the group consisting of a thread, filament, cord, rope, ribbon and sheet.
  • 9. The device of claim 1 wherein at least a portion of the elongated member comprises a straight wire or bristles.
  • 10. The device of claim 1 wherein the second energy transforming material comprises a filament.
  • 11. The device of claim 1 wherein at least a portion of the elongated member comprises a sleeve.
  • 12. The device of claim 1 wherein at least a portion of the elongated member comprises a braid, coil, knot, spiral or zigzag.
  • 13. The device of claim 1 wherein at least a portion of the elongated member comprises a tube or a cone.
  • 14. The device of claim 1 wherein the elongated member comprises a lumen.
  • 15. The device of claim 1 wherein movement of the actuator causes movement of the elongated member in an axial direction in relation to the first sheath.
  • 16. The device of claim 1 wherein at least one end of the elongated member is affixed to the actuator.
  • 17. The device of claim 1 wherein movement of the actuator causes the elongated member to retract inside the lumen of the first sheath.
  • 18. The device of claim 1 wherein the elongated member forms a closed loop wherein the two ends of the single wire joined to each other at the proximal end of said elongated member.
  • 19. The device of claim 1 wherein at least a portion of the elongated member comprises a single wire.
  • 20. The device of claim 1 wherein at least a portion of the second energy transferring material is interwoven with at least a portion of the first substantially non-conductive material.
RELATED APPLICATIONS

This application claims benefit of and priority to U.S. provisional application 60/714,374, filed Sep. 6, 2005 and U.S. provisional application 60/734,558, filed Nov. 8, 2005, the disclosures of each are incorporated by reference herein.

US Referenced Citations (286)
Number Name Date Kind
3874388 King et al. Apr 1975 A
4007743 Blake Feb 1977 A
4696300 Anderson Sep 1987 A
4710192 Liotta et al. Dec 1987 A
4832048 Cohen May 1989 A
4836204 Landymore et al. Jun 1989 A
4902508 Badylak et al. Feb 1990 A
4917089 Sideris Apr 1990 A
4921484 Hillstead May 1990 A
4944741 Hasson Jul 1990 A
4945912 Langberg Aug 1990 A
4946440 Hall Aug 1990 A
4956178 Badylak et al. Sep 1990 A
4967765 Turner et al. Nov 1990 A
5003990 Osypka Apr 1991 A
5007908 Rydell Apr 1991 A
5021059 Kensey et al. Jun 1991 A
5025799 Wilson Jun 1991 A
5108420 Marks Apr 1992 A
5156613 Sawyer Oct 1992 A
5171259 Inoue Dec 1992 A
5176687 Hasson et al. Jan 1993 A
5217435 Kring Jun 1993 A
5222974 Kensey et al. Jun 1993 A
5275826 Badylak et al. Jan 1994 A
5282827 Kensey et al. Feb 1994 A
5284488 Sideris Feb 1994 A
5304184 Hathaway et al. Apr 1994 A
5312341 Turi May 1994 A
5312435 Nash et al. May 1994 A
5334217 Das Aug 1994 A
5370644 Langberg Dec 1994 A
5385156 Oliva Jan 1995 A
5423882 Jackman et al. Jun 1995 A
5425744 Fagan et al. Jun 1995 A
5433727 Sideris Jul 1995 A
5451235 Lock et al. Sep 1995 A
5484385 Rishton Jan 1996 A
5486185 Freitas et al. Jan 1996 A
5507744 Tay et al. Apr 1996 A
5507811 Koike et al. Apr 1996 A
5540681 Strul et al. Jul 1996 A
5573533 Strul Nov 1996 A
5578045 Das Nov 1996 A
5597378 Jervis Jan 1997 A
5620461 Muijs Van De Moer et al. Apr 1997 A
5620479 Diederich Apr 1997 A
5626599 Bourne et al. May 1997 A
5630837 Crowley May 1997 A
5634936 Linden et al. Jun 1997 A
5636634 Kordis et al. Jun 1997 A
5649950 Bourne et al. Jul 1997 A
5653684 Laptewicz et al. Aug 1997 A
5669934 Sawyer Sep 1997 A
5676662 Fleischhacker et al. Oct 1997 A
5683411 Kavteladze et al. Nov 1997 A
5690675 Sawyer et al. Nov 1997 A
5702421 Schneidt Dec 1997 A
5709707 Lock et al. Jan 1998 A
5725552 Kotula et al. Mar 1998 A
5733294 Forber et al. Mar 1998 A
5733337 Carr, Jr. et al. Mar 1998 A
5741249 Moss et al. Apr 1998 A
5741297 Simon Apr 1998 A
5749895 Sawyer et al. May 1998 A
5797905 Fleischman et al. Aug 1998 A
5797907 Clement Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5800428 Nelson et al. Sep 1998 A
5800478 Chen et al. Sep 1998 A
5807384 Mueller Sep 1998 A
5810810 Tay et al. Sep 1998 A
5810884 Kim Sep 1998 A
5823956 Roth et al. Oct 1998 A
5846261 Kotula et al. Dec 1998 A
5849028 Chen Dec 1998 A
5853422 Huebsch et al. Dec 1998 A
5861003 Latson et al. Jan 1999 A
5865791 Whayne et al. Feb 1999 A
5879366 Shaw et al. Mar 1999 A
5893856 Jacob et al. Apr 1999 A
5895412 Tucker Apr 1999 A
5904703 Gilson May 1999 A
5919200 Stambaugh et al. Jul 1999 A
5927284 Borst et al. Jul 1999 A
5944738 Amplatz et al. Aug 1999 A
5948011 Knowlton Sep 1999 A
5954719 Chen et al. Sep 1999 A
5955110 Patel et al. Sep 1999 A
5957919 Laufer Sep 1999 A
5964782 Lafontaine et al. Oct 1999 A
5971980 Shermann Oct 1999 A
5976174 Ruiz Nov 1999 A
5993844 Abraham et al. Nov 1999 A
5997575 Whitson et al. Dec 1999 A
6004269 Crowley et al. Dec 1999 A
6004316 Laufer Dec 1999 A
6010517 Baccaro Jan 2000 A
6015378 Borst et al. Jan 2000 A
6016811 Knopp et al. Jan 2000 A
6024756 Huebsch et al. Feb 2000 A
6063080 Nelson et al. May 2000 A
6063085 Tay et al. May 2000 A
6077291 Das Jun 2000 A
6080182 Shaw et al. Jun 2000 A
6086581 Reynolds et al. Jul 2000 A
6086610 Duerig et al. Jul 2000 A
6102926 Tartaglia et al. Aug 2000 A
6106520 Laufer et al. Aug 2000 A
6106532 Koike et al. Aug 2000 A
6117159 Huebsch et al. Sep 2000 A
6123718 Tu et al. Sep 2000 A
6132438 Fleischman et al. Oct 2000 A
6135997 Laufer et al. Oct 2000 A
6143037 Goldstein et al. Nov 2000 A
6152144 Lesh et al. Nov 2000 A
6152918 Padilla et al. Nov 2000 A
6165183 Kuehn et al. Dec 2000 A
6171329 Shaw et al. Jan 2001 B1
6174322 Schneidt Jan 2001 B1
6187039 Hiles et al. Feb 2001 B1
6200313 Abe et al. Mar 2001 B1
6206907 Marino et al. Mar 2001 B1
6212426 Swanson Apr 2001 B1
6214029 Thill et al. Apr 2001 B1
6221092 Koike et al. Apr 2001 B1
6231516 Keilman et al. May 2001 B1
6231561 Frazier et al. May 2001 B1
6238415 Sepetka et al. May 2001 B1
6251128 Knopp et al. Jun 2001 B1
6270515 Linden et al. Aug 2001 B1
6283935 Laufer et al. Sep 2001 B1
6287317 Makower et al. Sep 2001 B1
6290674 Roue et al. Sep 2001 B1
6290699 Hall et al. Sep 2001 B1
6292700 Morrison et al. Sep 2001 B1
6306424 Vyakarnam et al. Oct 2001 B1
6312446 Huebsch et al. Nov 2001 B1
6325798 Edwards et al. Dec 2001 B1
6328727 Frazier et al. Dec 2001 B1
6336926 Goble Jan 2002 B1
6338726 Edwards et al. Jan 2002 B1
6338731 Laufer et al. Jan 2002 B1
6352561 Leopold et al. Mar 2002 B1
6355052 Neuss et al. Mar 2002 B1
6364853 French et al. Apr 2002 B1
6364876 Erb et al. Apr 2002 B1
6364878 Hall Apr 2002 B1
6368340 Malecki et al. Apr 2002 B2
6375671 Kobayashi et al. Apr 2002 B1
6379368 Corcoran et al. Apr 2002 B1
6398779 Buysse et al. Jun 2002 B1
6402772 Amplatz et al. Jun 2002 B1
6419669 Frazier et al. Jul 2002 B1
6430446 Knowlton Aug 2002 B1
6432119 Saadat Aug 2002 B1
6436088 Frazier et al. Aug 2002 B2
6440152 Gainor et al. Aug 2002 B1
6458100 Roue et al. Oct 2002 B2
6461327 Addis et al. Oct 2002 B1
6488706 Solymar Dec 2002 B1
6494881 Bales et al. Dec 2002 B1
6503247 Swartz et al. Jan 2003 B2
6506189 Rittman, III et al. Jan 2003 B1
6527767 Wang et al. Mar 2003 B2
6527786 Davis et al. Mar 2003 B1
6540742 Thomas et al. Apr 2003 B1
6544260 Markel et al. Apr 2003 B1
6551303 Van Tassel et al. Apr 2003 B1
6551344 Thill Apr 2003 B2
6558375 Sinofsky et al. May 2003 B1
6558385 McClurken et al. May 2003 B1
6582430 Hall Jun 2003 B2
6596013 Yang et al. Jul 2003 B2
6616655 Falwell et al. Sep 2003 B1
6623508 Shaw et al. Sep 2003 B2
6626901 Treat et al. Sep 2003 B1
6632223 Keane Oct 2003 B1
6641579 Bernardi et al. Nov 2003 B1
6650923 Lesh et al. Nov 2003 B1
6652517 Hall et al. Nov 2003 B1
6656206 Corcoran et al. Dec 2003 B2
6659105 Burbank et al. Dec 2003 B2
6666861 Grabek Dec 2003 B1
6666863 Wentzel et al. Dec 2003 B2
6673068 Berube Jan 2004 B1
6673090 Root et al. Jan 2004 B2
6676656 Sinofsky Jan 2004 B2
6701176 Halperin et al. Mar 2004 B1
6702835 Ginn Mar 2004 B2
6709432 Ferek-Patric Mar 2004 B2
6712804 Roue et al. Mar 2004 B2
6712815 Sampson et al. Mar 2004 B2
6712836 Berg et al. Mar 2004 B1
6723092 Brown et al. Apr 2004 B2
6730081 Desai May 2004 B1
6735532 Freed et al. May 2004 B2
6743184 Sampson et al. Jun 2004 B2
6743197 Edwards Jun 2004 B1
6755822 Reu et al. Jun 2004 B2
6764486 Natale Jul 2004 B2
6770070 Balbierz Aug 2004 B1
6776780 Mulier et al. Aug 2004 B2
6780183 Jimenez, Jr. et al. Aug 2004 B2
6796981 Wham et al. Sep 2004 B2
6802843 Truckai et al. Oct 2004 B2
6805130 Tasto et al. Oct 2004 B2
6813520 Truckai et al. Nov 2004 B2
6821273 Mollenauer Nov 2004 B2
6913579 Truckai et al. Jul 2005 B2
6939348 Malecki et al. Sep 2005 B2
7165552 Deem et al. Jan 2007 B2
20010014800 Frazier et al. Aug 2001 A1
20010034537 Shaw et al. Oct 2001 A1
20010037129 Thill Nov 2001 A1
20010039435 Roue et al. Nov 2001 A1
20010041914 Frazier et al. Nov 2001 A1
20010041915 Roue et al. Nov 2001 A1
20010049492 Frazier et al. Dec 2001 A1
20020010481 Jayaraman Jan 2002 A1
20020026094 Roth Feb 2002 A1
20020029048 Miller Mar 2002 A1
20020032462 Houser et al. Mar 2002 A1
20020035374 Borillo et al. Mar 2002 A1
20020052572 Franco et al. May 2002 A1
20020096183 Stevens et al. Jul 2002 A1
20020111645 Wang et al. Aug 2002 A1
20020111647 Khairkhahan et al. Aug 2002 A1
20020129819 Feldman et al. Sep 2002 A1
20020183786 Girton Dec 2002 A1
20020183787 Wahr et al. Dec 2002 A1
20030028213 Thill et al. Feb 2003 A1
20030045893 Ginn Mar 2003 A1
20030045901 Opolski Mar 2003 A1
20030050665 Ginn Mar 2003 A1
20030069575 Chin et al. Apr 2003 A1
20030073979 Naimark et al. Apr 2003 A1
20030088242 Prakash et al. May 2003 A1
20030100920 Akin et al. May 2003 A1
20030109778 Rashidi Jun 2003 A1
20030139819 Beer et al. Jul 2003 A1
20030144694 Chanduszko et al. Jul 2003 A1
20030181945 Opolski et al. Sep 2003 A1
20030191495 Ryan et al. Oct 2003 A1
20030191526 Van Tassel et al. Oct 2003 A1
20030195530 Thill Oct 2003 A1
20030195531 Gardiner et al. Oct 2003 A1
20030204203 Khairkhahan et al. Oct 2003 A1
20030208232 Blaeser et al. Nov 2003 A1
20040044361 Frazier et al. Mar 2004 A1
20040049207 Goldfarb et al. Mar 2004 A1
20040092973 Chanduszko et al. May 2004 A1
20040143277 Marino et al. Jul 2004 A1
20040143291 Corcoran et al. Jul 2004 A1
20040143293 Marino et al. Jul 2004 A1
20040143294 Corcoran et al. Jul 2004 A1
20040193147 Malecki et al. Sep 2004 A1
20040193239 Falwell et al. Sep 2004 A1
20040215187 Burbank Oct 2004 A1
20040220596 Frazier et al. Nov 2004 A1
20040220610 Kreidler et al. Nov 2004 A1
20040230185 Malecki et al. Nov 2004 A1
20040243122 Auth et al. Dec 2004 A1
20040254572 McIntyre et al. Dec 2004 A1
20040267191 Gifford et al. Dec 2004 A1
20040267306 Blaeser et al. Dec 2004 A1
20050021016 Malecki et al. Jan 2005 A1
20050034735 Deam et al. Feb 2005 A1
20050070887 Taimisto et al. Mar 2005 A1
20050080406 Malecki et al. Apr 2005 A1
20050125032 Whisenant et al. Jun 2005 A1
20050131401 Malecki et al. Jun 2005 A1
20050131460 Gifford, III et al. Jun 2005 A1
20060027241 Malecki et al. Feb 2006 A1
20060074410 Malecki et al. Apr 2006 A1
20060241581 Malecki et al. Oct 2006 A1
20060241582 Malecki et al. Oct 2006 A1
20060241583 Malecki et al. Oct 2006 A1
20060241584 Malecki et al. Oct 2006 A1
20060247612 Malecki et al. Nov 2006 A1
20060271030 Francis et al. Nov 2006 A1
20060271040 Horne et al. Nov 2006 A1
20060271089 Alejandro et al. Nov 2006 A1
20060276779 Malecki et al. Dec 2006 A1
20060276846 Malecki et al. Dec 2006 A1
20070010806 Malecki et al. Jan 2007 A1
Foreign Referenced Citations (39)
Number Date Country
0 317 067 May 1989 EP
0553259 Mar 1995 EP
1 013 227 Jun 2000 EP
1 046 375 Oct 2000 EP
1 222 897 Jul 2002 EP
0 750 905 Jan 2003 EP
2 407 985 May 2005 GB
WO 9513111 May 1995 WO
WO9625179 Aug 1996 WO
WO 9629946 Oct 1996 WO
WO9631157 Oct 1996 WO
WO9728744 Aug 1997 WO
WO9839063 Sep 1998 WO
WO9905977 Feb 1999 WO
WO9918862 Apr 1999 WO
WO9918864 Apr 1999 WO
WO9918870 Apr 1999 WO
WO9918871 Apr 1999 WO
WO0018331 Apr 2000 WO
WO0027292 May 2000 WO
WO 0074555 Dec 2000 WO
WO0121247 Mar 2001 WO
WO0130266 May 2001 WO
WO0130267 May 2001 WO
WO0130268 May 2001 WO
WO0149185 Jul 2001 WO
WO0217809 Mar 2002 WO
WO0224106 Mar 2002 WO
WO03022159 Mar 2003 WO
WO 03026525 Apr 2003 WO
WO03059152 Jul 2003 WO
WO03061481 Jul 2003 WO
WO03073944 Sep 2003 WO
WO03077733 Sep 2003 WO
WO 2004086944 Oct 2004 WO
WO 2004086951 Oct 2004 WO
WO 2005070316 Aug 2005 WO
WO2005070491 Aug 2005 WO
2005115231 Dec 2005 WO
Non-Patent Literature Citations (14)
Entry
International Search Report for International App. No. PCT/US2006/047479, mailed Aug. 28, 2007 (6 pgs.).
Written Opinion of the Searching Authority for International App. No. PCT/US2006/047479, mailed Aug. 28, 2007 (8 pgs.).
De Ponti, R., et al., “Trans-septal Catheterization for Radiofrequency Catheter Ablation of Cardiac Arrhythmias”, The European Society of Cardiology, 19:943-950 (1998).
“Elastic Deployment”, SMST-2000 Proceedings of the International Conference on Shape Memory and Superelastic Technologies, 3 pages (Apr. 30-May 4, 2000).
Hanson, James, et al., “Metals That Remember”, Science 81, 44-47 June.
Kramer, Paul, M.D., “PFO and Stroke: The Hidden Connection”, Endovascular Today.
Lavergne et al., “Transcatheter Radiofrequency Ablation of Atrial Tissue Using a Suction Catheter”, PACE, vol. 12:177-186, January Part II 1989.
Protsenko et al., “Electrosurgical Tissue Resection: A Numerical and Experimental Study”, Proceedings of SPIE, vol. 4954:64-70, (2003).
Ruiz et al., “The Puncture Technique: A New Method for Transcatheter Closure of Patent Foramen Ovale”, Catheterization and Cardiovascular Interventions, 53:369-372 (2001).
Sommer, et al., “New Transseptal Puncture Technique for Transcatheter Closure of Patent Foramen Ovale”, Mount Sinai Medical Center, Jun. 2002.
Stöckel, “Nitinol Medical Devices and Implants”, SMST-2000 Conference Proceedings, 531-541 (2001).
Szili-Torok, “Transseptal Left Heart Catheterisation guided by Intracardiac Echocardiography”, Heart 86:e11 (2001).
International Search Report for International Application No. PCT/US2006/034496, mailed Jan. 26, 2007 (5 pages).
Written Opinion of the International Searching Authority for International Application No. PCT/US2006/034496, mailed Jan. 26, 2007 (7 pages).
Related Publications (1)
Number Date Country
20070066864 A1 Mar 2007 US
Provisional Applications (2)
Number Date Country
60714374 Sep 2005 US
61734558 Nov 2005 US